CAS 202340-45-2

Eflucimibe

CAS: 202340-45-2

Eflucimibe

Pureza: ≥98%

Peso molecular: 469.72g/mol

Ref: 54-BUP11648

Eflucimibe

CAS: 202340-45-2

Eflucimibe (L0081), an ACAT inhibitor, treats cardiovascular, endocrine, and metabolic diseases, and helps in atherosclerosis and hyperlipidemia research.

Fórmula: C₂₉H₄₃NO₂S

Pureza: 99.49% - 99.97

Cor e Forma: Solid

Peso molecular: 469.72

Ref: TM-T27245L